Chronic bone infections due to Enterobacter cloacae: current therapeutic trends and clinical outcome.
Kanellakopoulou
K
K
4th Department of Internal Medicine, University of Athens, Greece.
Giannitsioti
E
E
Papadopoulos
A
A
Athanassia
S
S
Giamarellos-Bourboulis
E J
EJ
Giamarellou
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001850:Bone Diseases, Infectious / Q000188:drug therapy* / Q000601:surgery*; D015780:Carbapenems / Q000627:therapeutic use; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D024901:Drug Resistance, Multiple, Bacterial; D016972:Enterobacter cloacae; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D055815:Young Adult
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002939:Ciprofloxacin